x min read

Trending Tickers: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), American International Group, Inc. (NYSE:AIG), Myriad Genetics Inc. (NASDAQ:MYGN), Carlisle Companies (NYSE:CSL), Banc of California (NYSE:BANC)

Trending Tickers: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), American International Group, Inc. (NYSE:AIG), Myriad Genetics Inc. (NASDAQ:MYGN), Carlisle Companies (NYSE:CSL), Banc of California (NYSE:BANC)
Written by
Charles Donlon
Published on
November 6, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) cut the top end of its sales forecast for the blockbuster eye drug Eylea, citing slower adoption by patients with a type of diabetes-related swelling of the retina. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) belongs to Healthcare sector. Its net profit margin is 15.90% and weekly performance is -4.95%. On last trading day company shares ended up $368.51. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) distance from 50-day simple moving average (SMA50) is 1.87%. American International Group, Inc. (NYSE:AIG) reported third-quarter 2014 operating earnings per share (EPS) of $1.21, which outpaced the Zacks Consensus Estimate of $1.08 by 12% and the year-ago quarter EPS of 96 cents by 26%. With this result, the company kept its earnings streak alive and marked four straight quarters of earnings beat averaging 15.7%. American International Group, Inc. (NYSE:AIG) shares increased 0.71% in last trading session and ended the day at $53.78. AIG return on assets is 1.60%. American International Group, Inc. (NYSE:AIG) quarterly performance is 3.54%. On Nov. 3, Myriad Genetics Inc. (NASDAQ:MYGN) announced that it has signed an expanded companion diagnostic agreement with AbbVie, Inc. (NYSE:ABBV), a leading global biopharmaceutical company to use Tumor BRACAnalysis CDx™ as a companion diagnostic in support of AbbVie's novel poly (ADP-ribose) polymerase or PARP inhibitor, veliparib. On 05 November, Myriad Genetics Inc. (NASDAQ:MYGN) shares decreased -6.18% and was closed at $34.61. MYGN EPS growth in last 5 year was 10.30%. Myriad Genetics Inc. (NASDAQ:MYGN) year to date (YTD) performance is 64.97%. The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a regular quarterly dividend of $0.25 per share, payable on December 1, 2014 to shareholders of record at the close of business on November 19, 2014. Carlisle Companies Incorporated (NYSE:CSL) ended the last trading day at $88.98. Company weekly volatility is calculated as 1.14% and price to cash ratio as 7.09. Carlisle Companies Incorporated (NYSE:CSL) showed a weekly performance of 1.78%. On Oct 30, Banc of California, Inc. (NYSE:BANC) reported net income of $11.2 million and net income available to common shareholders of $10.3 million, or $0.31 per diluted common share for the quarter ended September 30, 2014. Banc of California, Inc. (NYSE:BANC) shares decreased -0.52% in last trading session and ended the day at $11.37. BANC return on assets is 0.50%. Banc of California, Inc. (NYSE:BANC) quarterly performance is -5.33%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.